bioAffinity Technologies, Inc. Common Stock (BIAF) is a publicly traded Healthcare sector company. As of July 22, 2026, BIAF trades at $0.72 with a market cap of $4.39M and a P/E ratio of -0.10. BIAF moved +2.11% today. Year to date, BIAF is -40.25%; over the trailing twelve months it is -93.56%. Its 52-week range spans $0.61 to $46.53. Rallies surfaces BIAF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest BIAF news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $0.72 |
| Market Cap | $4.39M |
| P/E Ratio | -0.10 |
| EPS | $-6.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $46.53 |
| 52-Week Low | $0.61 |
| Volume | 214.24K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.66M |
| Net Income | $-15.88M |
| Gross Margin | 0.00% |
BIAF analyst coverage data. Average price target: $0.00.